Home / Treatments / Sermorelin / Evidence
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Released: ·Last reviewed: ·Prices verified October 15, 2026·Methodology v4.1

Sermorelin: what the human evidence actually shows

Direct answer

Sermorelin is a synthetic fragment of growth hormone-releasing hormone. It stimulates the pituitary to produce and release the body's own growth hormone, rather than supplying growth hormone directly. It is prescribed off-label through telehealth and longevity clinics for adult growth-hormone optimisation, body composition, sleep and recovery.

What the evidence actually shows

Sermorelin does what it says mechanistically: it raises endogenous growth hormone and IGF-1. That is measurable and reasonably well-documented. What is much weaker is evidence that this translates into the outcomes it is sold for in healthy adults — fat loss, muscle gain, better sleep, slower ageing. The trials that exist are small, short, often uncontrolled, and frequently conducted in people with genuine growth-hormone deficiency, which is a different population from a healthy 45-year-old seeking optimisation. Extrapolating from deficiency treatment to healthy-adult enhancement is not a supported inference.

Three ways evidence gets overstated hereThree moves recur constantly in this category, and once you can name them you will see them everywhere. Mouse-to-human transfer: a striking longevity result in mice, presented as though it applies to you. Biomarker-for-outcome substitution: a study shows a blood level rose, and the marketing implies you will feel better or live longer. Deficiency-to-enhancement transfer: a treatment that helps people with a diagnosed deficiency is sold to healthy people seeking optimisation. None of these are valid inferences.

Frequently asked questions

What does Sermorelin cost through telehealth?

We have not verified a market price. On October 15, 2026, NexLife’s sermorelin injection page showed a regular price of $130.00 and was marked sold out, and Oak Longevity showed sermorelin pricing only after a free assessment. Ask any provider for the total monthly cost, including consultations and supplies, in writing.

Is Sermorelin FDA-approved?

No approved sermorelin product is on the U.S. market as of October 15, 2026. Its approved product, Geref, was discontinued, and FDA determined in 2013 that it was not withdrawn for safety or effectiveness reasons. Sermorelin is in none of FDA’s interim 503A compounding categories.

Does Sermorelin work?

Sermorelin prompts the pituitary to release growth hormone, so it can raise growth-hormone and IGF-1 levels. Evidence that this improves body composition, sleep or ageing in healthy adults is thin. We have not re-read the clinical literature for this update and cite no trial.

Sources

  1. U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
  2. PubMed / NIH — indexed human clinical literature.
  3. ClinicalTrials.gov — registered trials, where they exist.
  4. Our source hierarchy and pricing-verification methodology.

Spotted an error? Submit a correction.

Researched ByDr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed ByDr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.